Cerner could finish its current quarter with $1.33 billion in sales, according to Wall Street brokers and reported by Stock News Times.
Here are seven updates on the company's financials and stock activity:
1. During the second quarter of fiscal year 2017, the company posted $1.29 billion in sales. If analysts predictions hold true, the EHR vendor would see a 3.1 percent year-over-year growth rate.
2. Analysts project full-year 2018 sales to be $5.30 billion to $5.53 billion.
3. During the first quarter of fiscal year 2018, Cerner posted $1.29 billion in revenue, which fell short of analysts' expected $1.34 billion.
4. Cerner Vice Chairman Clifford Illig sold 3,000 shares of Cerner stock in a transaction dated May 7 at an average price of $58.32 for a total transaction of $174,960. Mr. Illig now holds 1,229,719 shares valued at $71,717,212.08.
5. Numerous investment firms recently added or reduced their shares in the company, and now, 79.92 percent of Cerner stock is now owned by hedge funds and other institutional investors.
6. Shares of Cerner opened the week at $61.34.
7. Cerner is expected to release its second-quarter earnings report July 26.
Editor's note: Numbers are based on a report from Zack's Premium Investment, as cited in Stock News Times. Numbers are a mean average based on a survey of sell-side research firms covering Cerner.
More articles on EHRs:
Mayo Clinic pulls off 25k-user Epic go-live: 3 questions with the consulting firm that helped them do it
Apple, Cerner & Microsoft are interested in buying athenahealth: Here's why this CEO says they won't
NYT: How this pediatrician used EHR data to unveil the Flint water crisis